Results 221 to 230 of about 276,945 (256)

Clinical development of novel therapeutics for castration‐resistant prostate cancer

Ca-A Cancer Journal for Clinicians, 2012
Matthew D Galsky, Alexander C Small, William K Oh   +2 more
exaly  

Monoaminergic drugs: General pharmacology

Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology, 1976
W, Haefely, G, Bartholini, A, Pletscher
openaire   +2 more sources

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

The resurgence of covalent drugs

Nature Reviews Drug Discovery, 2011
Thomas A Baillie, Adrian Whitty
exaly  

Targeting virulence: can we make evolution-proof drugs?

Nature Reviews Microbiology, 2014
Richard C Allen, Roman Popat, Stephen P Diggle   +2 more
exaly  

Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance

Nature Reviews Drug Discovery, 2017
Gordon Y C Cheung, Michael Otto
exaly  

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Therapeutic Innovation: Ethical Boundaries in the Initial Clinical Trials of New Drugs and Surgical Procedures

Ca-A Cancer Journal for Clinicians, 1970
exaly  

Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

Nature Reviews Drug Discovery, 2003
Donald M Coen
exaly  

Palliation and Life Prolongation With Anticancer Drugs

Ca-A Cancer Journal for Clinicians, 1966
exaly